Yim M - Search Results

1

Mitochondrial dynamics modulate the expression of pro-inflammatory mediators in microglial cells.

Park J, Choi H, Min JS, Park SJ, Kim JH, Park HJ, Kim B, Chae JI, Yim M, Lee DS. Park J, et al. Among authors: yim m. J Neurochem. 2013 Oct;127(2):221-32. doi: 10.1111/jnc.12361. Epub 2013 Jul 29. J Neurochem. 2013. PMID: 23815397 Free article.

2

Phosphodiesterase 4 inhibitor regulates the TRANCE/OPG ratio via COX-2 expression in a manner similar to PTH in osteoblasts.

Park H, Young Lee S, Lee DS, Yim M. Park H, et al. Among authors: yim m. Biochem Biophys Res Commun. 2007 Mar 2;354(1):178-83. doi: 10.1016/j.bbrc.2006.12.174. Epub 2007 Jan 2. Biochem Biophys Res Commun. 2007. PMID: 17222389

3

Nicotinamide adenine dinucleotide phosphate (NADPH) oxidase-dependent activation of phosphoinositide 3-kinase and p38 mitogen-activated protein kinase signal pathways is required for lipopolysaccharide-induced microglial phagocytosis.

Sun HN, Kim SU, Lee MS, Kim SK, Kim JM, Yim M, Yu DY, Lee DS. Sun HN, et al. Among authors: yim m. Biol Pharm Bull. 2008 Sep;31(9):1711-5. doi: 10.1248/bpb.31.1711. Biol Pharm Bull. 2008. PMID: 18758064 Free article.

4

Phosphodiesterase 3 and 4 negatively regulate receptor activator of nuclear factor-kappaB ligand-mediated osteoclast formation by prostaglandin E2.

Noh AL, Yang M, Lee JM, Park H, Lee DS, Yim M. Noh AL, et al. Among authors: yim m. Biol Pharm Bull. 2009 Nov;32(11):1844-8. doi: 10.1248/bpb.32.1844. Biol Pharm Bull. 2009. PMID: 19881295 Free article.

5

PDE4 inhibitor upregulates PTH-induced osteoclast formation via CRE-mediated COX-2 expression in osteoblasts.

Park H, No AL, Lee JM, Chen L, Lee SY, Lee DS, Yim M. Park H, et al. Among authors: yim m. FEBS Lett. 2010 Jan 4;584(1):173-80. doi: 10.1016/j.febslet.2009.11.043. FEBS Lett. 2010. PMID: 19925797 Free article.

6

PDE4 inhibitor suppresses PGE2-induced osteoclast formation via COX-2-mediated p27(KIP1) expression in RAW264.7 cells.

Chen L, Zheng T, Park H, Noh AL, Lee JM, Lee DS, Yim M. Chen L, et al. Among authors: yim m. Pharmazie. 2011 Mar;66(3):201-6. Pharmazie. 2011. PMID: 21553651

7

5-Lipoxygenase mediates RANKL-induced osteoclast formation via the cysteinyl leukotriene receptor 1.

Lee JM, Park H, Noh AL, Kang JH, Chen L, Zheng T, Lee J, Ji SY, Jang CY, Shin CS, Ha H, Lee ZH, Park HY, Lee DS, Yim M. Lee JM, et al. Among authors: yim m. J Immunol. 2012 Dec 1;189(11):5284-92. doi: 10.4049/jimmunol.1003738. Epub 2012 Oct 29. J Immunol. 2012. PMID: 23109727

8

Peroxiredoxin II negatively regulates lipopolysaccharide-induced osteoclast formation and bone loss via JNK and STAT3.

Park H, Noh AL, Kang JH, Sim JS, Lee DS, Yim M. Park H, et al. Among authors: yim m. Antioxid Redox Signal. 2015 Jan 1;22(1):63-77. doi: 10.1089/ars.2013.5748. Antioxid Redox Signal. 2015. PMID: 25074339 Free PMC article.

9

IDH2-deficient mice develop spinal deformities with aging.

Chae U, Park NR, Kim ES, Choi JY, Yim M, Lee HS, Lee SR, Lee S, Park JW, Lee DS. Chae U, et al. Among authors: yim m. Physiol Res. 2018 Jul 17;67(3):487-494. doi: 10.33549/physiolres.933711. Epub 2018 Mar 12. Physiol Res. 2018. PMID: 29527922 Free article.

10

Montelukast inhibits RANKL‑induced osteoclast formation and bone loss via CysLTR1 and P2Y12.

Kang JH, Lim H, Lee DS, Yim M. Kang JH, et al. Among authors: yim m. Mol Med Rep. 2018 Aug;18(2):2387-2398. doi: 10.3892/mmr.2018.9179. Epub 2018 Jun 15. Mol Med Rep. 2018. PMID: 29916540

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

297 results

Search Page

Filters